Workflow
春纪
icon
Search documents
春纪线上“退场”,丸美生物押注彩妆?
Bei Jing Shang Bao· 2025-10-20 09:22
丸美生物旗下美妆品牌春纪正在"悄然退场"。10月20日,北京商报记者发现,在淘宝天猫平台已经搜索 不到春纪旗舰店相关信息。有媒体报道,春纪天猫旗舰店发布《店铺终止经营公告》表示,"本店铺拟 于2025年10月26日自主终止经营"。而在更早的今年8月,就有多家媒体报道春纪天猫官方旗舰店下架了 所有产品链接,无法购买。 值得一提的是,北京商报记者在化妆品监管App上搜索发现,春纪产品的最后一款备案产品时间为2024 年7月30日,这意味着在过去一年多的日子里,春纪未向市场推出任何新品。从线下渠道的发展来看, 目前尚未搜索到春纪线下专柜。而这些信号似乎都在印证这一曾经颇具知名度的品牌的悄然离去。 与此同时,记者了解到,该品牌位于京东、楚楚街、蘑菇街、拼多多、卷皮等多家主流电商平台的店铺 已全部关闭。春纪微信公众号也早于2023年初停更;而春纪官方微博于2022年5月停更。 就上述相关信息,北京商报记者对丸美生物进行求证,截至目前未收到回应。 公开资料显示,丸美生物于2007年推出春纪,以"天然食材养肤"为核心理念,定位大众护肤市场,旨在 为年轻女性提供天然护肤方案。从为数不多的春纪被披露过的营收数据来看,该品牌曾是 ...
丸美生物业绩会:国货美妆近年来正展现强劲崛起势头
Core Viewpoint - The domestic beauty brand market in China is experiencing strong growth, driven by increasing consumer recognition and confidence in local brands, as stated by the CEO of Marubi Biotechnology during the 2024 annual and Q1 2025 earnings presentation [1] Financial Performance - Marubi Biotechnology achieved a net profit attributable to shareholders of 342 million yuan for the fiscal year 2024, representing a year-on-year increase of 31.69%, while the net profit after deducting non-recurring gains and losses was 327 million yuan, up 73.86% year-on-year [1] - In Q1 2025, the company reported a net profit attributable to shareholders of 135 million yuan, a year-on-year increase of 22.07%, with the net profit after deducting non-recurring gains and losses at 134 million yuan, up 28.57% year-on-year [1] - The stock price of Marubi Biotechnology has increased by over 150% since September 2024, with a closing limit up on May 15 [1] Strategic Transformation - The company has undergone a strategic transformation from a traditional beauty enterprise to a biotechnology beauty company, as indicated by the renaming of its stock from "Marubi Co., Ltd." to "Marubi Biotechnology" in 2024 [2] - Marubi Biotechnology emphasizes the importance of biotechnology in its current and future operations, particularly in the development and industrial application of key technologies such as recombinant collagen protein [2] Research and Development - In 2024, Marubi Biotechnology was recognized as a "National Research Center for Recombinant Functional Protein Technology," conducting 20 specialized studies on recombinant functional proteins throughout the year [2] - The company has made significant advancements in the development of various types of recombinant collagen proteins and has filed for 10 invention patents related to key technologies [2] Industry Trends - The beauty industry is witnessing accelerated penetration of advanced technologies such as artificial intelligence, synthetic biology, and smart manufacturing, which are driving industry upgrades [3] - Consumer demand is becoming more diverse and personalized, leading to higher expectations for quality, efficacy, and added value in beauty products and services [3] Sales and Distribution Strategy - Marubi Biotechnology is pursuing a multi-channel collaborative development strategy, with its brands already present in duty-free stores and actively exploring other channel opportunities [3]